Literature DB >> 22956259

A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model.

Louis Doré-Savard1, Nicolas Beaudet, Luc Tremblay, Yongjun Xiao, Martin Lepage, Philippe Sarret.   

Abstract

Bone metastases represent a frequent complication of advanced breast cancer. As tumor growth-induced bone remodeling progresses, episodes of severe pain and fractures of weight-bearing limbs increase. All of these skeletal-related events influence the patient's quality of life and survival. In the present study, we sought to determine whether some of these pain-related behaviors could be directly correlated to tumor progression and bone remodeling. For this purpose, we used a rat model of bone cancer pain based on the implantation of mammary carcinoma cells in the medullary cavity of the femur. The bone content and tumor growth were monitored over time by magnetic resonance imaging (MRI) and micro X-ray computed tomography (μCT). The same animals were evaluated for changes in their reflexive withdrawal responses to mechanical stimuli (allodynia) and weight-bearing deficits. As assessed by MRI, we found a negative correlation between tumor volume and allodynia or postural deficits throughout the experiment. Using μCT, we found that the bone volume/total volume (BV/TV) ratios for trabecular and cortical bone correlated with both mechanical hypersensitivity and weight-bearing impairment. However, whereas trabecular BV/TV stabilized between days 7 and 10 post-tumor detection, the cortical bone loss reached its maximum at that time. Our imaging approach also allowed us to consistently detect the tumor before the onset of pain, paving the way for the preemptive identification of at-risk patients. Altogether, these results improve our understanding of the events leading to tumor-induced bone pain and could eventually help in the design of novel strategies for the management of bone diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22956259     DOI: 10.1007/s10585-012-9530-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  73 in total

1.  MRI detection of early bone metastases in b16 mouse melanoma models.

Authors:  Karen M Gauvain; Joel R Garbow; Sheng-Kwei Song; Angela C Hirbe; Katherine Weilbaecher
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Denosumab: benefits of RANK ligand inhibition in cancer patients.

Authors:  Allan Lipton; Ira Jacobs
Journal:  Curr Opin Support Palliat Care       Date:  2011-09       Impact factor: 2.302

3.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

Review 4.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

5.  Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.

Authors:  Molly A Sevcik; Nancy M Luger; David B Mach; Mary Ann C Sabino; Christopher M Peters; Joseph R Ghilardi; Matthew J Schwei; Heidi Röhrich; Carmen De Felipe; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

Review 6.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

7.  Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Authors:  Mary Ann C Sabino; Joseph R Ghilardi; Joost L M Jongen; Cathy P Keyser; Nancy M Luger; David B Mach; Christopher M Peters; Scott D Rogers; Matthew J Schwei; Carmen de Felipe; Patrick W Mantyh
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

8.  Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

Authors:  Tamara King; Anna Vardanyan; Lisa Majuta; Ohannes Melemedjian; Ray Nagle; Anne E Cress; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2007-08-15       Impact factor: 6.961

Review 9.  Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.

Authors:  Colleen M Costelloe; Eric M Rohren; John E Madewell; Tsuyoshi Hamaoka; Richard L Theriault; Tse-Kuan Yu; Valerae O Lewis; Jingfei Ma; R Jason Stafford; Ana M Tari; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Lancet Oncol       Date:  2009-06       Impact factor: 41.316

10.  Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.

Authors:  Annette Ø Jensen; Jacob B Jacobsen; Mette Nørgaard; Mellissa Yong; Jon P Fryzek; Henrik T Sørensen
Journal:  BMC Cancer       Date:  2011-01-24       Impact factor: 4.430

View more
  4 in total

1.  Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Authors:  Michel Demeule; Nicolas Beaudet; Anthony Régina; Élie Besserer-Offroy; Alexandre Murza; Pascal Tétreault; Karine Belleville; Christian Ché; Alain Larocque; Carine Thiot; Richard Béliveau; Jean-Michel Longpré; Éric Marsault; Richard Leduc; Jean E Lachowicz; Steven L Gonias; Jean-Paul Castaigne; Philippe Sarret
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

Review 2.  Using animal models to understand cancer pain in humans.

Authors:  Gillian L Currie; Emily S Sena; Marie T Fallon; Malcolm R Macleod; Lesley A Colvin
Journal:  Curr Pain Headache Rep       Date:  2014-06

3.  Effect of sex in the MRMT-1 model of cancer-induced bone pain.

Authors:  Sarah Falk; Tamara Al-Dihaissy; Laura Mezzanotte; Anne-Marie Heegaard
Journal:  F1000Res       Date:  2015-07-31

4.  Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management.

Authors:  David André Barrière; Élora Midavaine; Louis Doré-Savard; Karyn Kirby; Luc Tremblay; Jean-François Beaudoin; Nicolas Beaudet; Jean-Michel Longpré; Roger Lecomte; Martin Lepage; Philippe Sarret
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.